President Trump and top congressional leaders yesterday failing to reach an agreement to avoid a government shutdown during a private meeting held at the White House on Monday. After that meeting, Republican lawmakers pinned the blame on Democrats with Vice President JD Vance predicting a shutdown this week. >> We have disagreements about tax policy, but you don't shut that government down. We have disagreements about healthcare policy, but you don't shut the government down. You don't use your policy disag ...

policy, but you don't shut the government down. You don't use your policy disagreements as leverage to not pay our troops, to not have essential services of government actually function. You don't say the fact that you disagree about a particular tax provision is an excuse for shutting down the people's government and all the essential services that come along with it.If you look at what Chuck Schumer has said in the past consistently, it's whatever our disagreements are, let's negotiate with them. Let's ta ...

Core Insights - Tenet Healthcare reported strong Q2 2025 earnings, with adjusted EPS of $4.02, significantly exceeding Wall Street expectations of $2.87, and revenue of $5.27 billion, surpassing GAAP forecasts of $5.16 billion [1][5][10] Financial Performance - Adjusted EPS increased by 74% year-over-year from $2.31 to $4.02 [2] - Revenue grew by 3.2% from $5.11 billion in Q2 2024 to $5.27 billion in Q2 2025 [2] - Adjusted EBITDA rose 18.6% to $1.12 billion compared to $945 million in Q2 2024 [2] - Free cash flow reached $743 million, a 23.4% increase from $602 million in Q2 2024 [2][8] Segment Performance - Ambulatory Care segment saw net operating revenue increase by 11.3% to $1.27 billion, with adjusted EBITDA rising 11.4% [6] - Hospital Operations revenue grew modestly by 0.9% to $4.00 billion, with adjusted EBITDA up 25% [7] - Same-hospital admissions increased by 1.6%, while outpatient visits and emergency room visits declined by 3.2% and 4.7%, respectively [7] Strategic Focus - Tenet Healthcare is focused on optimizing its portfolio for growth and profitability, emphasizing the expansion of its outpatient services through United Surgical Partners International (USPI) [3][4] - The company is divesting underperforming hospitals and shifting care to outpatient settings, which are seen as more cost-effective [4] Future Guidance - The company raised its full-year FY2025 guidance, projecting adjusted EBITDA between $4.40 and $4.54 billion and adjusted EPS between $15.55 and $16.21 [10] - Revenue is expected to reach between $20.95 and $21.25 billion, with ambulatory net operating revenues projected between $5.0 and $5.15 billion [10]